Ibrutinib in Patients With Refractory/Relapsed Non-GCB Diffuse Large B-cell Lymphoma Non-candidates to ASCT
Clinical trial NCT02692248 · COMPLETED
Trial details
- NCT number
- NCT02692248
- Sponsor
- Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-07
- Primary completion
- 2018-11-08
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.